Structural differences between the putative carbohydrate-recognition domains of human IL-1 alpha, IL-1 beta and IL-1 receptor antagonist obtained by in silico modeling

被引:5
|
作者
Vergoten, Gerard [1 ]
Zanetta, Jean-Pierre [1 ]
机构
[1] Univ Sci & Tech Lille Flandres Artois, Unite Glycobiol Struct & Fonctionnelle, CNRS, UMR 8576, F-59655 Villeneuve Dascq, France
关键词
cytokine; lectin; oligosaccharide; ganglioside; modeling; signaling;
D O I
10.1007/s10719-006-9021-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In a previous report (Cebo et al. J Biol Chem 276 (2001) 5685-5691), it was established that biologically active recombinant human IL-1 alpha and IL-1 beta had different carbohydrate-binding properties. IL-1 alpha recognized a di-antennary N-glycan with two alpha 2-3-linked sialic acid residues, whereas IL-1 beta recognized the GM(4), a alpha 2-3-linked sialylated glycosphingolipid. These different carbohydrate-binding properties of two interleukins binding to the same receptor (IL-1R) could explain why these molecules had different biological effects and cell specificities. Molecular modeling of the ligands and in silico docking experiments defined putative carbohydrate-recognition domains localized in the same area of the two molecules, a domain different from that defined as the type I IL-1R binding domain. The calculated pattern of hydrogen bonding and of van der Waals interactions fulfilled the essential features observed for calcium-independent lectins (mammalian, viral or bacterial). The analysis of the same domain of the third members of this family of molecules, the IL-1R-antagonist, indicated it did not fulfill the criteria for carbohydrate-recognition domains. It is proposed that its role as a pure antagonist is due to the absence of lectin activity and consequently explained its inability to associate IL-1R with other surface molecular complexes necessary for signaling.
引用
收藏
页码:183 / 193
页数:11
相关论文
共 50 条
  • [31] Local suppression of IL-1 by receptor antagonist in the rat model of corneal alkali injury
    Yamada, J
    Dana, MR
    Sotozono, C
    Kinoshita, S
    EXPERIMENTAL EYE RESEARCH, 2003, 76 (02) : 161 - 167
  • [32] Involvement of the IL-1 system in experimental autoimmune encephalomyelitis and multiple sclerosis: Breaking the vicious cycle between IL-1β and GM-CSF
    Pare, Alexandre
    Mailhot, Benoit
    Levesque, Sebastien A.
    Lacroix, Steve
    BRAIN BEHAVIOR AND IMMUNITY, 2017, 62 : 1 - 8
  • [33] Endothelial-specific knockdown of interleukin-1 (IL-1) type 1 receptor differentially alters CNS responses to IL-1 depending on its route of administration
    Ching, San
    Zhang, Hao
    Belevych, Natalya
    He, Lingli
    Lai, Wenmin
    Pu, Xin-an
    Jaeger, Laura B.
    Chen, Qun
    Quan, Ning
    JOURNAL OF NEUROSCIENCE, 2007, 27 (39) : 10476 - 10486
  • [34] Serum levels of soluble IL-2 receptor α, IL-6 and IL-1 receptor antagonist in schizophrenia before and during neuroleptic administration
    Akiyama, K
    SCHIZOPHRENIA RESEARCH, 1999, 37 (01) : 97 - 106
  • [35] IL-1 Family Antagonists in Mouse and Human Skin Inflammation
    Martin, Praxedis
    Goldstein, Jeremie D.
    Mermoud, Loic
    Diaz-Barreiro, Alejandro
    Palmer, Gaby
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [36] STRUCTURE-FUNCTION ANALYSIS OF HUMAN IL-1-ALPHA - IDENTIFICATION OF RESIDUES REQUIRED FOR BINDING TO THE HUMAN TYPE-I IL-1 RECEPTOR
    LABRIOLATOMPKINS, E
    CHANDRAN, C
    VARNELL, TA
    MADISON, VS
    JU, G
    PROTEIN ENGINEERING, 1993, 6 (05): : 535 - 539
  • [37] Sex differences in the regulation of brain IL-1β in response to chronic stress
    Barnard, David F.
    Gabella, Kristin M.
    Kulp, Adam C.
    Parker, Austin D.
    Dugan, Patrick B.
    Johnson, John D.
    PSYCHONEUROENDOCRINOLOGY, 2019, 103 : 203 - 211
  • [38] NEUTRALIZATION OF ENDOGENOUS IL-1 RECEPTOR ANTAGONIST EXACERBATES AND PROLONGS INFLAMMATION IN RABBIT IMMUNE COLITIS
    FERRETTI, M
    CASINIRAGGI, V
    PIZARRO, TT
    EISENBERG, SP
    NAST, CC
    COMINELLI, F
    JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (01) : 449 - 453
  • [39] Acute-phase responses in transgenic mice with CNS overexpression of IL-1 receptor antagonist
    Lundkvist, J
    Sundgren-Andersson, AK
    Tingsborg, S
    Östlund, P
    Engfors, C
    Alheim, K
    Bartfai, T
    Iverfeldt, K
    Schultzberg, M
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 1999, 276 (03) : R644 - R651
  • [40] Mature Dendritic Cell Suppression by IL-1 Receptor Antagonist on Retinal Pigment Epithelium Cells
    Sugita, Sunao
    Kawazoe, Yuko
    Imai, Ayano
    Usui, Yoshihiko
    Iwakura, Yoichiro
    Isoda, Kikuo
    Ito, Masataka
    Mochizuki, Manabu
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (05) : 3240 - 3249